Advances in HPV Diagnostic Testing: Technologies Enhancing Detection of High-Risk Strains Linked to Cervical Cancer
With over 12 different types of human papilloma virus (HPV) that can cause cancer, it is the leading cause of cervical cancer in women. The HPV/Pap smear co-test has improved the accuracy of cervical cancer screening; however the test has several limitations. Recent advancements in molecular diagnostics have led to the development of genotype-specific HPV tests that accurately detect and differentiate HPV strains, including high-risk oncogenic types such as HPV-16 and HPV-18.
In this webinar you will:
- Learn about HPV type-specific testing
- Explore the recent trends in HPV diagnostics
- Discover urine-specific genotyping chemistry, which can provide a non-invasive, sensitive method for HPV detection
Speaker: Steve Hawkins, Ph.D., Meridian Life Science Molecular Product Manager